Rocket Lab’s $2.36 Billion Backlog Says the Neutron Delay Doesn’t Matter — Here’s Why

Rich Duprey

Tue, August 11, 2026 at 6:09 PM GMT+3 4 min read

Quick Read

RKLB secured over $1 billion in Q2 new awards, pushing its backlog to $2.36 billion as shares fell on Neutron delay noise.
Beck is prioritizing Neutron reusability over speed, betting SpaceX's repeatable-cadence model creates far more value than a rushed maiden flight.
The pending Iridium deal adds $870 million in recurring annual revenue, nearly doubling Rocket Lab's scale and anchoring its full-stack space platform.
Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Rocket Lab didn't make the cut. Grab the names FREE today.

The space economy has a timing problem. Investors want quarterly proof of progress, but rockets don't care about earnings calendars -- they fly when the hardware, the weather, and the physics all agree at once. That mismatch showed up again this week when Rocket Lab (NASDAQ:RKLB) posted one of the best quarters in its history and still watched its stock slide.

Rocket Lab

The space stock reported record second-quarter revenue of $234 million, up 62% year over year, alongside a backlog that swelled to $2.36 billion. Shares still fell nearly 10% in after-hours trading, though are down just 1.5% this morning. The culprit wasn't the numbers -- it was one phrase from CEO Peter Beck about Neutron, the medium-lift rocket investors have been waiting years to see fly: the launch window is "narrowing."

The Business Beneath Neutron Is Already Working

Strip away the rocket that hasn't launched yet, and Rocket Lab's underlying business is scaling fast. Space Systems -- satellites, components, spacecraft -- grew 39% sequentially, and the company landed more than $581 million in new awards during the quarter, including a $397 million flat-sat contract with the Space Development Agency and its first government geostationary contracts. Add in $437 million of new launch bookings and a backlog that now stretches past 90 missions, and Rocket Lab locked in more than $1 billion in new business in a single reporting period.

Act now: the analyst who called NVIDIA in 2010 just named his top 10 AI stocks — and Rocket Lab didn't make the cut. Grab the names FREE today.

That matters because it shows the company isn't a one-rocket bet. Adjusted EBITDA loss narrowed to $8.8 million, far better than guidance called for, and Q3 revenue is guided to $250 million to $265 million, up roughly 10% sequentially. Granted, gross margin guidance ticked down on business mix and Mynaric integration costs, and free cash outflow widened to $110 million as Neutron spending ramped. That's the trade-off: spending today to own tomorrow's launch capacity.

24/7 Wall St.

Record $234M revenue meets the cold reality of rocket science delays. Is the $2.4B backlog worth the 'wait' for Neutron? © 24/7 Wall St.

Why Beck Is Willing to Miss the Window

Neutron hardware remains on track for pad delivery in Q4, but Beck told analysts the window for a launch by year-end is "narrowing." The Wall Street Journal has separately reported the maiden flight could slip further. Investors hate that word -- delay -- but the logic holds up.

Beck isn't optimizing for a single successful flight. He's optimizing for reusability and repeatable cadence, because a rocket that flies once is a science project; a rocket that flies dozens of times a year at a predictable cost is a business. SpaceX proved that lesson is worth more than any single launch date. If Rocket Lab gets reusability right instead of rushing Flight 1, Neutron becomes the missing piece connecting a company that already designs satellites, builds components, and manufactures spacecraft into a full-stack space platform -- with recurring revenue layered on top once its pending Iridium (NASDAQ:IRDM) acquisition closes.

That Iridium detail deserves more weight than "layer on top" suggests. Iridium generates roughly $870 million in annual revenue. Rocket Lab's own Q2 run-rate annualizes to about $936 million. After the-close, Iridium isn't a side business -- it's close to half of combined revenue, and it's the recurring half, unlike lumpy launch and contract revenue.

Cantor Fitzgerald cited the record revenue, the Iridium deal, and Neutron's Q4 launch trajectory as the drivers behind raising its target to $122 from $96 -- a firm looking past the stock's reaction and toward the platform Rocket Lab is assembling.

Key Takeaway

Rocket Lab's Q2 print was genuinely strong -- record revenue, record backlog, and proof that Space Systems can carry the company while Neutron finishes qualification. The delay chatter will keep rattling short-term traders, and elevated cash burn is a legitimate risk worth watching until first flight and the ramp that follows.

For investors willing to look past the next launch date, the thesis hasn't changed: Rocket Lab is building a rare full-stack space company, and Iridium's recurring revenue only strengthens the case. In the end, patience with this timeline is likely to be rewarded more than anxiety about it.